Sharing of Antigenic Determinants Between the Nicotinic Ach Receptor & Proteins in Ecoli, Prot Vulgaris & Pneumoniae
NEJM 312:221-225, Stefansson,K.,et al, 1985
Intensive Care of the Myasthenic Patient
Neurol 48 (Suppl 5) :S70-S75997., Mayer,S.A., 1997
Myasthenic Crisis:Clinical Features, Mortality, Comp, & Risk Factors for Prolonged Intubation
Neurol 48:1253-1254, Thomas,C.E.,et al, 1997
Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
Stroke 33:862-875, Gorelick,P.B., 2002
Bacterial Infection as a Cause of Multiple Sclerosis
Lancet 360:352-353, Wolfson,C. &Talbot,P., 2002
Multiple Sclerosis and Antecedent Infections
Neurol 54:2307-2310, Marrie,R.A.,et al, 2000
Chlamydia Pneumoniae Infection of the Central Nervous System in Multiple Sclerosis
Ann Neurol 46:6-14,4, Sriram,S.,et al, 1999
Multiple Sclerosis Associated with Chlamydia Pneumoniae Infection of the CNS
Neurol 50:571-572, Sriram,S.,et al, 1998
Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998
The Spectrum of Antecedent Infections in Guillain-Barre Syndrome
Neurol 51:1110-1115, Jacobs,B.C.,et al, 1998
Campylobacter Jejuni Infection and Guillain-Barre Syndrome
NEJM 333:1374-1379, 14151995., Rees,J.H.,et al, 1995
Serologic Evidence of Previous Campylobacter Jejuni Infection in Patients with the Guillain-Barre Syndrome
Ann Int Med 118:947-953, Mishu,B.,et al, 1993
Mycoplasma Antibody in Guillain-Barre Syndrome & Other Neurological Disorders
Ann Neurol 7:108-112, Goldschmidt,B.,et al, 1980